Is the US prepared to deal with another pandemic or widespread health crisis?
I will assess U.S. pandemic preparedness by reviewing recent official reports, expert analyses, and key readiness indicators from public health agencies and independent evaluations.Gathering details from key recent evaluations and reports.No, the US is not fully prepared for another pandemic or widespread health crisis, though it has improved in some technical areas since COVID-19. Assessments from government watchdogs, bipartisan commissions, the WHO, CDC, and independent experts consistently highlight progress alongside persistent and, in some recent analyses, worsening gaps in coordination, funding, workforce, leadership continuity, and systemic resilience. No country is fully ready per global benchmarks, and the US’s strong paper rankings have not always translated to effective real-world performance.[1]
Key Improvements Since COVID-19
Post-2020 investments and reforms have strengthened certain capabilities:
CDC testimony in late 2024 highlighted these as building blocks for faster detection, testing, and response.[2]
Persistent and Critical Gaps
Multiple authoritative reviews identify unfinished business and vulnerabilities:
Recent Developments and Expert Concerns (2025 onward)
Analyses from 2025–2026 indicate backsliding in some areas under policy shifts: OPPR largely unstaffed or minimal (from peaks of ~15–20 to near-empty or 1–2 people at times); reported CDC staff reductions; redirects at NIH/NIAID away from some pandemic/biodefense research toward other priorities; funding cuts or pauses for certain countermeasures/mRNA work; and reduced international engagement (e.g., WHO-related). Multiple experts and outlets describe the US as less prepared than during or immediately after COVID, with weakened detection, R&D, and coordination capacity—raising risks for threats like H5N1 or novel pathogens.[11]
Public health infrastructure faces ongoing strain from workforce shortages, chronic disease burdens, and competing priorities. Models suggest a non-trivial chance of another severe pandemic in coming decades.
Bottom Line
The US has stronger tools in surveillance, stockpiles, and some technology than in 2019–2020, and institutional knowledge from COVID exists. However, it lacks fully sustained, coordinated, adequately funded, trusted, and resilient systems across federal, state, and local levels—plus consistent political prioritization. Execution risks (as seen in COVID despite high GHS rankings), open recommendations, funding cliffs, leadership gaps, and recent erosions mean the country is not adequately prepared for a major novel pathogen, biothreat, or concurrent crises. Experts from bipartisan commissions, GAO, CDC (in calling for resources), and independent analyses urge sustained investment, clearer authorities, workforce rebuilding, trust-building, and treating pandemics as core national security priorities to close the gaps. Preparedness is a continuous process, not a one-time fix; current trajectory leaves significant vulnerability.
Citations (11)
- https://legalclarity.org/global-health-security-index-how-countries-are-ranked/
Backs: “worsening gaps in coordination, funding, workforce, leadership continuity, and systemic resilience.”
- https://www.cdc.gov/washington/testimony/2024/t20241114.htm
Backs: “Syndromic surveillance covers most hospital EDs, wastewater monitoring and forecasting (via CDC’s Center for Forecasting and Outbreak Analytics) have advanced, and platforms like the “One CDC” Data Platform aim for better real-time integration.”
- https://bidenwhitehouse.archives.gov/briefing-room/statements-releases/2025/01/14/report-the-biden-harris-administration-roadmap-for-pandemic-preparedness-and-response/
Backs: “Stockpiles and supply chains: The Strategic National Stockpile (SNS) was significantly restocked (e.g., reports of 70× more N95s, far more gloves/gowns/ventilators than pre-pandemic levels). Domestic PPE manufacturing efforts and “warm base” public-private lab partnerships for rapid test development/surge capacity…”
- https://www.presidency.ucsb.edu/documents/fact-sheet-biden-harris-administration-releases-global-health-security-annual-report
Backs: “Medical countermeasures and tech: Advances in mRNA/platform technologies, prototype pathogen approaches (NIH), and stockpiling (e.g., for H5N1) occurred. Global Health Security investments exceeded $3 billion since 2020, supporting international detection/response.”
- https://www.who.int/publications/i/item/9789240105409
Backs: “Organizational changes: Creation of the White House Office of Pandemic Preparedness and Response Policy (OPPR) in 2023, CDC readiness enhancements, and use of biological incident playbooks.”
- https://ghsindex.org/country/united-states/
Backs: “GHS Index: The US ranked #1 globally in the 2021 Global Health Security Index (score ~75.9/100; earlier 2019 also top), strong in prevention, detection, and some response metrics—though the index itself notes even top scorers have major gaps, and real-world COVID performance lagged rankings.”
- https://www.gao.gov/products/gao-24-107175
Backs: “GAO findings: Hundreds of open recommendations (e.g., 220 of 428 as of April 2024) on HHS leadership/coordination for public health emergencies, medical supply shortage mitigation plans, comprehensive testing strategies, medical countermeasure manufacturing, data systems (duplication/privacy issues across ~99…”
- https://biodefensecommission.org/reports/the-national-blueprint-for-biodefense/
Backs: “Fragmented leadership, insufficient intelligence/attribution/deterrence, science/tech gaps, weak preparedness at all levels, detection/surveillance shortfalls, and response/recovery issues persist. It calls for immediate action on 36 recommendations (leadership elevation, sustained investment, ending…”
- https://center-forward.org/basic/pandemic-preparedness-strengthening-the-u-s-response-framework-2/
Backs: “Funding and authorities: Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) faces large projected shortfalls (tens of billions). The Pandemic and All-Hazards Preparedness Act (PAHPA) has faced reauthorization challenges/lapses.”
- https://www.nejm.org/doi/full/10.1056/NEJMp2406427
Backs: “Other issues: Supply chain fragility, antimicrobial resistance, inequities in healthcare access, declining public trust/misinformation challenges, and concurrent disaster strains on emergency resources.”
- https://www.cnn.com/2025/03/17/health/pandemic-preparedness-office-trump-bird-flu
Backs: “engagement (e.g., WHO-related). Multiple experts and outlets describe the US as less prepared than during or immediately after COVID, with weakened detection, R&D, and coordination capacity—raising risks for threats like H5N1 or novel pathogens.”